MRI Biomarkers Distinguish Progressive Supranuclear Palsy from Idiopathic Normal Pressure Hydrocephalus
Kingston — Tuesday June 9th, 2020 — On May 14th, 2020, MDLinx; an online medical research distributor shared news of a study conducted seeking improved methods of differentiating PSP (Progressive Supranuclear Palsy) and iNPH (Idiopathic Normal Pressure Hydrocephalus) during diagnosis. Historically, the two conditions, which share various clinical and radiological characteristics (Movement impairment & cognitive decline) have been difficult to distinguish from one another.
Using MRI imaging to measure differences in the ventricular enlargement of iNPH and PSP patients demonstrated 98.5% effectiveness in identifying which conditions the study subjects were experiencing. This study included 107 probable PSP patients, 27 iNPH patients and 43 control subjects. Previous methods of differentiation including measuring callosal angle (The corpus callosum is a nerve fiber bundle connecting the right and left hemispheres of the brain) demonstrated a predictive effectiveness of 70% in the same study candidates. © 2020 International Parkinson and Movement Disorder Society
News Provided by: MDLinx (Daily medical news. Research and resources for healthcare professionals and patients)
Link to abstract: Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy
The PSP Society of Canada serves patients and families dealing with Progressive Supranuclear Palsy (PSP) and related diseases such as Multiple System Atrophy (MSA) and Corticobasal Degeneration (CBD). For more information please visit. www.pspsocietycanada.ca
Sharing of medical news by the PSP Society of Canada is not intended as advice, support or endorsement for specific studies or outcomes distributed.